SB 706375High affinity, non-peptide UT receptor antagonist CAS# 733734-61-7 |
- MK-4305
Catalog No.:BCC1760
CAS No.:1030377-33-3
- SB-408124 Hydrochloride
Catalog No.:BCC1929
CAS No.:1431697-90-3
- Allopurinol
Catalog No.:BCC3720
CAS No.:315-30-0
- TCS 1102
Catalog No.:BCC4063
CAS No.:916141-36-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 733734-61-7 | SDF | Download SDF |
PubChem ID | 21023902 | Appearance | Powder |
Formula | C20H22BrF3N2O5S | M.Wt | 539.36 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO | ||
Chemical Name | 2-bromo-4,5-dimethoxy-N-[3-[(3R)-1-methylpyrrolidin-3-yl]oxy-4-(trifluoromethyl)phenyl]benzenesulfonamide | ||
SMILES | CN1CCC(C1)OC2=C(C=CC(=C2)NS(=O)(=O)C3=C(C=C(C(=C3)OC)OC)Br)C(F)(F)F | ||
Standard InChIKey | BPOWQJYAMDEAFF-CYBMUJFWSA-N | ||
Standard InChI | InChI=1S/C20H22BrF3N2O5S/c1-26-7-6-13(11-26)31-16-8-12(4-5-14(16)20(22,23)24)25-32(27,28)19-10-18(30-3)17(29-2)9-15(19)21/h4-5,8-10,13,25H,6-7,11H2,1-3H3/t13-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | High affinity, non-peptide antagonist of the urotensin-II (UT) receptor. Exhibits high affinity for mammalian UT receptors, including human, mouse and rat (Ki values are 9.3, 19.1 and 20.7 nM respectively, in HEK293 cells expressing recombinant UT receptors). Also inhibits binding of radiolabeled urotensin to endogenous human UT receptors (Ki = 5.4 nM in a whole-cell binding assay). Displays ≥100-fold selectivity for the human UT receptor over 86 different receptors, ion channels, enzymes, transporters and nuclear hormones. |
SB 706375 Dilution Calculator
SB 706375 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.854 mL | 9.2702 mL | 18.5405 mL | 37.081 mL | 46.3512 mL |
5 mM | 0.3708 mL | 1.854 mL | 3.7081 mL | 7.4162 mL | 9.2702 mL |
10 mM | 0.1854 mL | 0.927 mL | 1.854 mL | 3.7081 mL | 4.6351 mL |
50 mM | 0.0371 mL | 0.1854 mL | 0.3708 mL | 0.7416 mL | 0.927 mL |
100 mM | 0.0185 mL | 0.0927 mL | 0.1854 mL | 0.3708 mL | 0.4635 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- SCH 50911
Catalog No.:BCC5692
CAS No.:733717-87-8
- Niclosamide monohydrate
Catalog No.:BCC5212
CAS No.:73360-56-2
- 9-O-Acetyl-4,4'-di-O-methyllariciresinol
Catalog No.:BCN1367
CAS No.:73354-15-1
- Albanin A
Catalog No.:BCN3290
CAS No.:73343-42-7
- Macbecin I
Catalog No.:BCC7551
CAS No.:73341-72-7
- 3-Hydroxy-9,10-Dimethoxypterocarpan
Catalog No.:BCC8101
CAS No.:73340-41-7
- Methylnissolin
Catalog No.:BCN1368
CAS No.:733-40-4
- BAY 61-3606
Catalog No.:BCC1406
CAS No.:732983-37-8
- Deoxynojirimycin hydrochloride
Catalog No.:BCN2626
CAS No.:73285-50-4
- 1,4-Dihydro-1,2-dimethyl-4-oxo-3-quinolinecarboxylic acid
Catalog No.:BCN1369
CAS No.:73281-83-1
- 5-O-Caffeoylshikimic acid
Catalog No.:BCN7929
CAS No.:73263-62-4
- Moringin
Catalog No.:BCN7722
CAS No.:73255-40-0
- AR 231453
Catalog No.:BCC5143
CAS No.:733750-99-7
- Norandrostenedione
Catalog No.:BCC9103
CAS No.:734-32-7
- Dehydrobruceine A
Catalog No.:BCN7620
CAS No.:73435-47-9
- 1-Deoxymannojirimycin hydrochloride
Catalog No.:BCC6995
CAS No.:73465-43-7
- Tetrachyrin
Catalog No.:BCN4776
CAS No.:73483-88-2
- 7-Acetyllycopsamine
Catalog No.:BCN2000
CAS No.:73544-48-6
- cis-ACBD
Catalog No.:BCC6587
CAS No.:73550-55-7
- Mevastatin
Catalog No.:BCN2568
CAS No.:73573-88-3
- 27-p-Coumaroyloxyursolic acid
Catalog No.:BCN4288
CAS No.:73584-67-5
- Omeprazole
Catalog No.:BCC1254
CAS No.:73590-58-6
- (-)-Bicuculline methobromide
Catalog No.:BCC6555
CAS No.:73604-30-5
- 3-Hydroxybenzylamine
Catalog No.:BCN1804
CAS No.:73604-31-6
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.[Pubmed:15852036]
Br J Pharmacol. 2005 Jul;145(5):620-35.
1. SB-706375 potently inhibited [(125)I]hU-II binding to both mammalian recombinant and 'native' UT receptors (K(i) 4.7+/-1.5 to 20.7+/-3.6 nM at rodent, feline and primate recombinant UT receptors and K(i) 5.4+/-0.4 nM at the endogenous UT receptor in SJRH30 cells). 2. Prior exposure to SB-706375 (1 microM, 30 min) did not alter [(125)I]hU-II binding affinity or density in recombinant cells (K(D) 3.1+/-0.4 vs 5.8+/-0.9 nM and B(max) 3.1+/-1.0 vs 2.8+/-0.8 pmol mg(-1)) consistent with a reversible mode of action. 3. The novel, nonpeptidic radioligand [(3)H]SB-657510, a close analogue of SB-706375, bound to the monkey UT receptor (K(D) 2.6+/-0.4 nM, B(max) 0.86+/-0.12 pmol mg(-1)) in a manner that was inhibited by both U-II isopeptides and SB-706375 (K(i) 4.6+/-1.4 to 17.6+/-5.4 nM) consistent with the sulphonamides and native U-II ligands sharing a common UT receptor binding domain. 4. SB-706375 was a potent, competitive hU-II antagonist across species with pK(b) 7.29-8.00 in HEK293-UT receptor cells (inhibition of [Ca(2+)](i)-mobilization) and pK(b) 7.47 in rat isolated aorta (inhibition of contraction). SB-706375 also reversed tone established in the rat aorta by prior exposure to hU-II (K(app) approximately 20 nM). 5. SB-706375 was a selective U-II antagonist with >/=100-fold selectivity for the human UT receptor compared to 86 distinct receptors, ion channels, enzymes, transporters and nuclear hormones (K(i)/IC(50)>1 microM). Accordingly, the contractile responses induced in isolated aortae by KCl, phenylephrine, angiotensin II and endothelin-1 were unaltered by SB-706375 (1 microM). 6. In summary, SB-706375 is a high-affinity, surmountable, reversible and selective nonpeptide UT receptor antagonist with cross-species activity that will assist in delineating the pathophysiological actions of U-II in mammals.